Simultaneously Targeting Obesity and Pain: The STOP Trial (STOP)

April 13, 2016 updated by: Elizabeth Amy Janke, University of the Sciences in Philadelphia

A Randomized Clinical Trial of an Integrated Behavioral Self-management Intervention Simultaneously Targeting Obesity and Pain: The STOP Trial

The purpose of this study is to determine whether an integrated behavioral treatment approach can help overweight or obese individuals who also have chronic pain reduce their weight and manage their pain symptoms. The goal of this research is to develop better treatments for individuals with chronic pain and overweight or obesity. All participants in this study will receive treatment for weight management and/or pain symptoms. Participants will be assigned at random (like we picked it blindly out of a hat) to receive either: (1) Standard behavioral treatment for weight loss; or (2) Standard behavioral treatment for pain management; or (3) Integrated behavioral treatment for weight loss and pain.

Study Overview

Study Type

Interventional

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

  • Name: Research Assistant(s)

Study Locations

    • Pennsylvania
      • Philadelphia, Pennsylvania, United States, 19104
        • Recruiting
        • University of the Sciences

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Adults aged ≥ 18
  • Body mass index (BMI) ≥ 25
  • Chronic, non-cancer pain (pain at a level ≥ 4 on a scale of 0-10 on a majority of the days for 6 months or more prior to study participation)

Exclusion Criteria:

  • Have an unstable medical or psychiatric condition
  • Meet criteria for current substance abuse or dependence
  • Meet the criteria for bulimia
  • Non-fluent in spoken or written English
  • Currently pregnant, pregnant within the past 6 months, trying to get pregnant in the next 3 months
  • Demonstrate significant cognitive or sensorimotor impairment precluding treatment engagement
  • Already participating in a similar structured diet or exercise program or pain self-management program or plans to begin such a program outside the study during the next month
  • At risk for significant adverse cardiovascular events with moderate activity
  • Plans to relocate within the upcoming 12 months

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: STOP Intervention
The STOP treatment includes content designed to simultaneously and explicitly target both chronic pain and obesity. Treatment components are drawn from evidence-based interventions for chronic pain and obesity, separately.
Active Comparator: Standard Care Weight (SCW)
The weight loss intervention includes content focused around nutrition and eating habits, stimulus control and behavioral change, and physical activity. This content has been chosen because of its demonstrated effectiveness and importance in behavioral interventions to reduce weight.
Active Comparator: Standard Care Pain (SCP)
The chronic pain intervention is focused around reconceptualization of pain, decreasing catastrophizing, and increasing self-efficacy for pain. This content has been chosen because of its demonstrated effectiveness and importance in non-pharmacological interventions to improve pain management.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in weight from baseline to 12-months
Time Frame: Baseline, up to 12 months
Body weight measured using a calibrated digital scale during assessment visits.
Baseline, up to 12 months
Change in pain intensity from baseline to 12 months
Time Frame: Baseline, up to 12 months
Pain intensity as measured on a numeric ratings scale (NRS) of 0 (no pain) to 10 (worst pain imaginable).
Baseline, up to 12 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in pain disability from baseline to 12 months
Time Frame: Baseline, up to 12 months
As measured by West Haven Yale Multidimensional Pain Inventory (WHYMPI).
Baseline, up to 12 months
Change in quality of life from baseline to 12 months
Time Frame: Baseline, up to 12 months
As measured by the SF-36.
Baseline, up to 12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Elizabeth A Janke, PhD, University of the Sciences in Philadelphia

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Primary Completion (Anticipated)

January 1, 2017

Study Registration Dates

First Submitted

March 24, 2014

First Submitted That Met QC Criteria

March 27, 2014

First Posted (Estimate)

April 1, 2014

Study Record Updates

Last Update Posted (Estimate)

April 15, 2016

Last Update Submitted That Met QC Criteria

April 13, 2016

Last Verified

April 1, 2016

More Information

Terms related to this study

Other Study ID Numbers

  • SAP# 4100057688

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Obesity

Clinical Trials on Intervention Simultaneously Targeting Obesity and Pain

3
Subscribe